Research grants/Industry funded researchNext Generation ProgramSkoltech Biomedical InitiativeSkoltech Translational and Research Innovation Program – STRIPUMNIKSystems biology fellowship
Novel long non-coding RNAs as potential biomarkers for diagnostics of liver cancer
Development of the technology of genetic evaluation of breeding pigs for economic-useful traits based on the methods of gene and genomic analysis and high-precision mass spectrometry to ensure the competitiveness of domestic breeding pig
Engineering thermophage particles for studying virus assembly
Identification of Key genetic/epigenetic Marker(s) in cervical carcinogenesis and development of corresponding Molecular Therapeutics for precision medicine of cervical cancer
Systems biology fellowship program
Obtaining and biochemical characterization of Cas9 protein with CJSC
Relationship between interference and adaptation during the action of Type I-E CRISPR-Cas system of Escherichia coli
Computational approach for discovery of new CRISPR-Cas associated proteins
Study of the mechanisms of foreign DNA recognition by bacterial defense system BREX from Escherichi coli HS
Delivery of New Nucleases by AAV for Gene Therapy of Hereditary Diseases
Study of the regulation of expression of the genes of the restriction-modification Kpn2I system
Validation of a novel target for therapy - under NDA agreement
lncRNA LL35 as a regulator of Foxa 2 expression in vitro and in vivo - a probable target for diagnostics and therapeutics
Identification and functional validation of cancer-specific splicing changes caused by somatic mutations in structural pre-mRNA elements
Novel chemical modifications in guide RNAs for genome editing by CRISPR-Cas9
CRISPR/Cas9 based genome engineering in P. putida
Study of DNA-protein interactions in terminal complexes of bacteriophages infecting thermophilic bacteria
Search for the biological role of the TERP protein encoded in telomerase RNA
Towards classification of immunogenic T-cell epitopes based on physicochemical characteristics, self homology and the structure of recognizing T-cell repertoire
Cancer cell - specific RNA interference in vivo
Next Generation Program (Skoltech — MIT Joint Projects) covers the whole range of academic and institution development activities. That includes research, education, innovation and academic services towards establishing and promoting a mutually beneficial longterm bilateral collaboration between Skoltech and MIT, as well as further development of Skoltech work streams.

Regulation of Antitumor Response via Modulation of Ubr‐Ubiquitin Ligases In Vivo
Search and Development of New Genome Editing Tools for Biomedicine and Biotechnology
The Skoltech Biomedical Initiative (SBI) is an interdisciplinary cross-CREI program designed to get ready for collaboration with the Moscow International Medical Cluster at Skolkovo. The SBI is intended to nucleate new projects and to integrate them into a focused cross-CREI program that will refine and solidify Skoltech’s mission in biomedical relevant areas of research, education and innovation.

Magnetic nanoparticles and carbon nanotubes as enhancers for targeted RNA delivery in vivo
Personalized bacteriophage therapy of clostridium Difficile Infections
Machine learning and pattern recognition for the development of diagnostic and clinical prognostic prediction tools in psychiatry line mental disorders and neurology
Deciphering the cause of human pregancy lose by exome analysis of abortuses

Skoltech Translational and Research Innovation Program awards one year of funding  for translational research to bridge the gap between laboratory and marketplace and drives innovation and entrepreneurship in Russia. The Program provides critical support for participating teams to help establish proof of concept and provide assistance with advancing their technology towards commercialization, including pre-start up identification of high potential market opportunities, intellectual property management, and, if appropriate, team development. It helps to ensure that the invention meets the market technological requirements and finds its niche. It is developed in collaboration with the Deshpande Center for Technological Innovation at the Massachusetts Institute of Technology (MIT). Both The Deshpande Center and MIT have a proven track record of success in technology commercialisation.

Metagenomic approach for oil and gas industry
Targeted delivery of modified RNAs to the liver – an alternative Hepatitis C therapeutics
Development of Personal Genetic Screening System
A Platform Approach to Develop New Antibiotic Leads Based on Microcins

Foundation of Assistance to Small Innovative Enterprises (Bortnik’s foundation) is a non-profit organization set up by the Russian Government in 1994, formed in accordance with the Decree of the Government. The Foundation is classified as one of Russia’s most important scientific development institutions. UMNIK is the pre-seed funding program aimed to support young individual scientists by providing 500 000 rubles as nonrefundable nontaxable grant through multi-staged selection; selection of the winners is carried out in accredited institute by the expert panel (scientists and experts, business representatives, foundation representatives) prepared by Skoltech and approved by the Foundation.

Main objectives of the program:
– Provide state support for young scientists who want to fulfill their potential through innovation, and encouraging participation of young people in science, technology and innovation;
– Conduct research by young scientists in order to implement their results in the economy;
– Preparing young scientists for creation of small innovative enterprises, necessary for the application of research results.

UMNIK awards:

Comprehensive characterization of CRISPR-linked genes
Interpretable model for chromatin interaction probability prediction